Basic Information
RNALocate ID: | RLID:11002712 |
RNA Symbol: | hsa-miR-196b-5p |
Localization: | Extracellular vesicle |
RNA Information
RNA Name: | hsa-miR-196b |
RNA ID: | miRBase:MIMAT0001080 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 22849433 |
Tissue/Cell Line: | HEK-293T cells |
Method: | Next-generation RNA sequencing |
Description: | The total numbers of reads >15 bp matching each miRNA were calculated. These values were then normalized to number of reads per million mapped (RPMM) in each library, to enable direct comparison of expression levels. As a measure of the relative levels of expression of individual miRNAs in cells and EVs, the log (base two) of the ratio of the read number in EVs over that in cells was calculated (log2 (EV/cell)). The miRNA expression data for cells and EVs is presented in Additional file 1: Table S1. Data are collected from Table S1. |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:01002254 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
RLID:01002255 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
RLID:01002256 | Nucleolus | HeLa cells | 23940654 |
RLID:11002709 | Exosome | Brain tissue | 23382797 |
RLID:11002710 | Exosome | Plasma | 23663360 |
RLID:11002711 | Exosome | B cell lymphoma cell lines|EBV-transformed lymphoblastoid B cells | 25242326 |
RLID:11002713 | Microvesicle | Seminal plasma | 23539611 |
RLID-D:11000446 | Microvesicle | Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine | |
RLID-D:11001222 | Exosome | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-196b-5p | Peripheral arterial disease | MNDR-E-MI-24129 |
MNDR | hsa-miR-196b-5p | Oral squamous cell carcinoma | MNDR-E-MI-24130 |
MNDR | hsa-miR-196b-5p | Large cell neuroendocrine cancer | MNDR-E-MI-24131 |
MNDR | hsa-miR-196b-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-24132 |
MNDR | hsa-miR-196b-5p | Lymphoma | MNDR-E-MI-24133 |
MNDR | hsa-miR-196b-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-24134 |
MNDR | hsa-miR-196b-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-24135 |
MNDR | hsa-miR-196b-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-24136 |
MNDR | hsa-miR-196b-5p | Breast cancer luminal | MNDR-E-MI-24137 |
MNDR | hsa-miR-196b-5p | Niemann-pick disease type c | MNDR-E-MI-24138 |
MNDR | hsa-miR-196b-5p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-24139 |
MNDR | hsa-miR-196b-5p | Dermatomyositis | MNDR-E-MI-24140 |
MNDR | hsa-miR-196b-5p | Prostate cancer | MNDR-E-MI-24141 |
MNDR | hsa-miR-196b-5p | Gastric cancer | MNDR-E-MI-24142 |
MNDR | hsa-miR-196b-5p | Esophageal carcinoma | MNDR-E-MI-24143 |
MNDR | hsa-miR-196b-5p | Seizures | MNDR-E-MI-24144 |
MNDR | hsa-miR-196b-5p | Mixed lineage leukaemia (mll)-rearranged leukaemia | MNDR-E-MI-24145 |
MNDR | hsa-miR-196b-5p | Acute leukemia | MNDR-E-MI-24146 |
MNDR | hsa-miR-196b-5p | Huntington disease | MNDR-E-MI-24147 |
MNDR | hsa-miR-196b-5p | Chorea | MNDR-E-MI-24148 |
MNDR | hsa-miR-196b-5p | Uterine fibroid | MNDR-E-MI-24149 |
MNDR | hsa-miR-196b-5p | Lung cancer | MNDR-E-MI-24150 |
MNDR | hsa-miR-196b-5p | Down syndrome | MNDR-E-MI-24151 |
MNDR | hsa-miR-196b-5p | Parkinson disease | MNDR-E-MI-24152 |
MNDR | hsa-miR-196b-5p | Niemann-pick disease | MNDR-E-MI-24153 |
MNDR | hsa-miR-196b-5p | Breast cancer | MNDR-E-MI-24154 |
MNDR | hsa-miR-196b-5p | Pancreatic cancer | MNDR-E-MI-24155 |
MNDR | hsa-miR-196b-5p | HCV | MNDR-E-MI-24156 |
MNDR | hsa-miR-196b-5p | Rectum adenocarcinoma | MNDR-E-MI-24157 |
MNDR | hsa-miR-196b-5p | Nephroblastoma | MNDR-E-MI-24158 |
MNDR | hsa-miR-196b-5p | Colon adenocarcinoma | MNDR-E-MI-24159 |
MNDR | hsa-miR-196b-5p | Prostate adenocarcinoma | MNDR-E-MI-24160 |
MNDR | hsa-miR-196b-5p | Carcinoma ductal breast | MNDR-E-MI-24161 |
MNDR | hsa-miR-196b-5p | Glioblastoma | MNDR-E-MI-24162 |
MNDR | hsa-miR-196b-5p | Glioma | MNDR-E-MI-24163 |
MNDR | hsa-miR-196b-5p | Osteosarcoma | MNDR-E-MI-24164 |
MNDR | hsa-miR-196b-5p | Inclusion body myositis | MNDR-E-MI-24165 |
MNDR | hsa-miR-196b-5p | Breast carcinoma | MNDR-E-MI-24166 |
MNDR | hsa-miR-196b-5p | Pancreatic ductal adenocarcinoma | MNDR-E-MI-24167 |
MNDR | hsa-miR-196b-5p | Gastric adenocarcinoma | MNDR-E-MI-24168 |
MNDR | hsa-miR-196b-5p | Lung squamous cell carcinoma | MNDR-E-MI-24169 |
MNDR | hsa-miR-196b-5p | Non-small cell lung adenocarcinoma | MNDR-E-MI-24170 |
MNDR | hsa-miR-196b-5p | Lung adenocarcinoma | MNDR-E-MI-24171 |
MNDR | hsa-miR-196b-5p | Adrenocortical carcinoma | MNDR-E-MI-24172 |
MNDR | hsa-miR-196b-5p | Thyroid carcinoma | MNDR-E-MI-24173 |
MNDR | hsa-miR-196b-5p | Papillary thyroid carcinoma | MNDR-E-MI-24174 |
MNDR | hsa-miR-196b-5p | Pancreatic adenocarcinoma | MNDR-E-MI-24175 |
MNDR | hsa-miR-196b-5p | Brain stem cancer | MNDR-E-MI-24176 |
MNDR | hsa-miR-196b-5p | Carcinoma renal cell | MNDR-E-MI-24177 |
MNDR | hsa-miR-196b-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-24178 |
MNDR | hsa-miR-196b-5p | Renal clear cell carcinoma | MNDR-E-MI-24179 |
MNDR | hsa-miR-196b-5p | Cholangiocarcinoma | MNDR-E-MI-24180 |
MNDR | hsa-miR-196b-5p | Esophageal cancer | MNDR-E-MI-24181 |
MNDR | hsa-miR-196b-5p | Lung small cell carcinoma | MNDR-E-MI-24182 |
MNDR | hsa-miR-196b-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-24183 |
MNDR | hsa-miR-196b-5p | Testicular germ cell cancer | MNDR-E-MI-24184 |
MNDR | hsa-miR-196b-5p | Breast invasive carcinoma | MNDR-E-MI-24185 |
MNDR | hsa-miR-196b-5p | Hepatocellular carcinoma | MNDR-E-MI-24186 |
MNDR | hsa-miR-196b-5p | Embryonal cancer | MNDR-E-MI-24187 |
MNDR | hsa-miR-196b-5p | B-cell lymphoma | MNDR-E-MI-24188 |
MNDR | hsa-miR-196b-5p | Rheumatoid arthritis | MNDR-E-MI-24189 |
MNDR | hsa-miR-196b-5p | Retinoblastoma | MNDR-E-MI-24190 |
MNDR | hsa-miR-196b-5p | Abdominal aortic aneurysm | MNDR-E-MI-24191 |
MNDR | hsa-miR-196b-5p | Hodgkin lymphoma | MNDR-E-MI-24192 |
MNDR | hsa-miR-196b-5p | Tonsil cancer | MNDR-E-MI-24193 |
MNDR | hsa-miR-196b-5p | Acute myelocytic leukemia | MNDR-E-MI-24194 |
MNDR | hsa-miR-196b-5p | Colorectal cancer | MNDR-E-MI-24195 |
MNDR | hsa-miR-196b-5p | Nasopharynx carcinoma | MNDR-E-MI-24196 |
MNDR | hsa-miR-196b-5p | Multiple myeloma | MNDR-E-MI-24197 |
MNDR | hsa-miR-196b-5p | Hypoxia | MNDR-E-MI-24198 |
MNDR | hsa-miR-196b-5p | Uterine cervical neoplasms | MNDR-E-MI-24199 |
MNDR | hsa-miR-196b-5p | Nasopharyngeal cancer | MNDR-E-MI-24200 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | BACH1 | Homo sapiens | RR00209417 |
TOP